Zhejiang Tianyu Pharmaceutical(300702.SZ): Linhai Tianyu passed the on-site inspection of the European Medicines Agency.

Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its subsidiary, Linhai Tianyu Pharmaceutical Co., Ltd. (referred to as "Linhai Tianyu"), underwent an on-site GMP inspection by the European Directorate for the Quality of Medicines & HealthCare (EDQM) for the Active Pharmaceutical Ingredient CEP (Certificate of Suitability of the European Pharmacopoeia) from October 18 to October 20, 2023. The company recently received the inspection certificate issued by the EDQM, which was successfully passed. The active pharmaceutical ingredient and CEP certificate involved in the inspection are for CEP2013-159/Valsartan.